Drugs by condition
Drugs approved for type 2 diabetes
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
54
Still marketed, NDA or BLA
Drug classes
12
Novel drugs
22
New molecular entities and new biologics
In development
40+
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for type 2 diabetes.
- Onswik (Insulin Efsitora Alfa-Gobe) · Eli Lilly and CO NovelSep 23, 2026
- Arbli (Losartan Potassium) · Scienture Mar 13, 2025
- Zituvimet Xr (Metformin Hydrochloride, Sitagliptin) · Zydus Lifesciences Jul 18, 2024
- Zituvimet (Metformin Hydrochloride, Sitagliptin) · Zydus Lifesciences Nov 3, 2023
- Zituvio (Sitagliptin) · Zydus Lifesciences Oct 18, 2023
All approved drugs for type 2 diabetes, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 266 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Sodium-Glucose Cotransporter 2 Inhibitor (7)
- Inpefa Sotagliflozin · Lexicon Pharms INC · 2023
- Brenzavvy Bexagliflozin · Theracosbio · 2023
- Jardiance Empagliflozin · Boehringer Ingelheim · 2014
- Trijardy Xr Empagliflozin, Linagliptin, Metformin Hydrochloride · Boehringer Ingelheim · 2020
- Synjardy Xr Empagliflozin, Metformin Hydrochloride · Boehringer Ingelheim · 2016
- Synjardy Empagliflozin, Metformin Hydrochloride · Boehringer Ingelheim · 2015
- Glyxambi Empagliflozin, Linagliptin · Boehringer Ingelheim · 2015
Dipeptidyl Peptidase 4 Inhibitor (6)
- Tradjenta Linagliptin · Boehringer Ingelheim · 2011
- Zituvimet Xr Metformin Hydrochloride, Sitagliptin · Zydus Lifesciences · 2024
- Zituvimet Metformin Hydrochloride, Sitagliptin · Zydus Lifesciences · 2023
- Zituvio Sitagliptin · Zydus Lifesciences · 2023
- Jentadueto Xr Linagliptin, Metformin Hydrochloride · Boehringer Ingelheim · 2016
- Jentadueto Linagliptin, Metformin Hydrochloride · Boehringer Ingelheim · 2012
GLP-1 Receptor Agonist (4)
Insulin Analog (3)
- Xultophy 100/3.6 Insulin Degludec, Liraglutide · Novo · 2016
- Soliqua 100/33 Insulin Glargine, Lixisenatide · Sanofi-Aventis US · 2016
- Basaglar Insulin Glargine · Eli Lilly and CO · 2015
Sulfonylurea (3)
- Duetact Glimepiride, Pioglitazone Hydrochloride · Takeda Pharms USA · 2006
- Glucotrol Xl Glipizide · Pfizer · 1994
- Diabeta Glyburide · Sanofi Aventis US · 1984
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist (1)
- Mounjaro Tirzepatide · Eli Lilly and CO · 2022
Nonsteroidal Mineralocorticoid-Receptor Antagonist (1)
- Kerendia Finerenone · Bayer Hlthcare · 2021
P2Y12 Platelet Inhibitor (1)
- Brilinta Ticagrelor · Astrazeneca · 2011
Angiotensin 2 Receptor Blocker (1)
- Avapro Irbesartan · Sanofi Aventis US · 1997
Progestin Antagonist (1)
- Korlym Mifepristone · Corcept Therap · 2012
Peroxisome Proliferator Receptor alpha Agonist (1)
- Antara (Micronized) Fenofibrate · Lupin · 2004
Class not listed in FDA's data (25)
- Onswik Insulin Efsitora Alfa-Gobe · Eli Lilly and CO · 2026
- Steglatro Ertugliflozin · Msd Sub Merck · 2017
- Ozempic Semaglutide · Novo · 2017
- Farxiga Dapagliflozin · Astrazeneca Ab · 2014
- Invokana Canagliflozin · Janssen Pharms · 2013
- Nesina Alogliptin Benzoate · Takeda Pharms USA · 2013
- Januvia Sitagliptin Phosphate · Msd · 2006
- Welchol Colesevelam Hydrochloride · Cosette · 2000
- Actos Pioglitazone Hydrochloride · Takeda Pharms USA · 1999
- Lipitor Atorvastatin Calcium · Upjohn · 1996
- Cozaar Losartan Potassium · Organon · 1995
- Arbli Losartan Potassium · Scienture · 2025
- Atorvaliq Atorvastatin Calcium · Cmp Dev LLC · 2023
- Steglujan Ertugliflozin, Sitagliptin Phosphate · Msd Sub Merck · 2017
- Segluromet Ertugliflozin, Metformin Hydrochloride · Msd Sub Merck · 2017
- Invokamet Xr Canagliflozin, Metformin Hydrochloride · Janssen Pharms · 2016
- Xigduo Xr Dapagliflozin, Metformin Hydrochloride · Astrazeneca Ab · 2014
- Invokamet Canagliflozin, Metformin Hydrochloride · Janssen Pharms · 2014
- Kazano Alogliptin Benzoate, Metformin Hydrochloride · Takeda Pharms USA · 2013
- Oseni Alogliptin Benzoate, Pioglitazone Hydrochloride · Takeda Pharms USA · 2013
- Janumet Xr Metformin Hydrochloride, Sitagliptin Phosphate · Msd Sub Merck · 2012
- Cycloset Bromocriptine Mesylate · Veroscience · 2009
- Janumet Metformin Hydrochloride, Sitagliptin Phosphate · Msd Sub Merck · 2007
- Actoplus Met Metformin Hydrochloride, Pioglitazone Hydrochloride · Takeda Pharms USA · 2005
- Caduet Amlodipine Besylate, Atorvastatin Calcium · Pharmacia · 2004
Drugs in development for type 2 diabetes
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- CagrilintidePhase 320 trials
Novo Nordisk · Obesity, Overweight, Type 2 Diabetes
- RetatrutideLY3437943Phase 316 trials
Eli Lilly · Obesity, Overweight, Type 2 Diabetes
- HRS9531Phase 313 trials
Fujian Shengdi Pharmaceutical Co., Ltd. · Type 2 Diabetes, Chronic Management of Body Weight, Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- NNC0487-0111Phase 312 trials
Novo Nordisk · Obesity, Overweight, Obstructive Sleep Apnoea
- BofanglutideGZR18, BofanglutidaPhase 311 trials
Gan & Lee Pharmaceuticals. · Type 2 Diabetes Mellitus (T2DM), Obstructive Sleep Apnea (OSA), Obesity/Overweight in Adult
- HRS-7535Phase 310 trials
Shandong Suncadia Medicine Co., Ltd. · Type 2 Diabetes, Chronic Kidney Disease, Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity
- UBT251Phase 310 trials
The United Bio-Technology (Hengqin) Co., Ltd. · Obesity, Obesity &Amp; Overweight, Diabetes Mellitus, Type 2
- ElecoglipronPhase 39 trials
AstraZeneca · Type 2 Diabetes Mellitus, Obesity, Overweight
- LenbelintideAZD6234Phase 39 trials
AstraZeneca · Obesity or Overweight, Obesity, Overweight
- ZenagamtidePhase 39 trials
Novo Nordisk · Obesity, Overweight, Type 2 Diabetes
- OlatorepatideHS-20094Phase 38 trials
Jiangsu Hansoh Pharmaceutical Co., Ltd. · Type 2 Diabetes, Overweight or Obesity, Overweight or Obesity Without Diabetes
- ObicetrapibPhase 37 trials
NewAmsterdam Pharma · Lipidemia, Preclinical Alzheimer's Disease, Antioxidant Absorption
- AleniglipronPhase 36 trials
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics · Obesity, Overweight, Chronic Weight Management
- CagriSemaCagrilintide B and Semaglutide IPhase 36 trials
Novo Nordisk · Obesity, Diabetes Mellitus, Type 2, Hypertension
- MWN109 1Phase 36 trials
Shanghai Minwei Biotechnology Co., Ltd · Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM)
- MWN109 2Phase 36 trials
Shanghai Minwei Biotechnology Co., Ltd · Overweight , Obesity, Type 2 Diabetes Mellitus (T2DM)
- ASC30 A1ASC30Phase 35 trials
Ascletis Pharma (China) Co., Limited · Chronic Weight Management, Obesity, Overweight
- BGM0504Phase 35 trials
BrightGene Bio-Medical Technology Co., Ltd. · Type 2 Diabetes (T2DM), Overweight or Obese Participants Without Diabetes, Obesity
- HDM1005Phase 35 trials
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Obstructive Sleep Apnea (OSA) and Obesity, Obesity, Type 2 Diabetes
- MazdutideLY3305677Phase 35 trials
Eli Lilly · Type 2 Diabetes, Obesity, Overweight
5 discontinued brand-name drugs whose label still names it
More on type 2 diabetes: recruiting trials · published research
Related in cardiovascular and metabolic: Type 1 diabetes · Obesity and weight management · High blood pressure (hypertension) · Heart failure · High cholesterol · High triglycerides · Atrial fibrillation · Blood clots (DVT and pulmonary embolism) · Stroke prevention · Coronary artery disease and heart attack
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.